Skip to content
HowShorted

OptiNose, Inc. short interest in 2023

In 2023, OptiNose, Inc.'s disclosed short interest ran from 3.31% of shares outstanding on 13 Jan 2023 to 3.27% on 29 Dec 2023, a change of -0.04 percentage points. The year's high was 4.09% on 14 Jul 2023 and its low 2.13% on 15 Jun 2023, averaging 3.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.38 days on 28 Feb 2023. Full history: OptiNose, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for OptiNose, Inc. in 2023

2023 in figures

Start of year
3.31% (13 Jan 2023)
End of year
3.27% (29 Dec 2023)
Change
-0.04 pp
High
4.09% (14 Jul 2023)
Low
2.13% (15 Jun 2023)
Average
3.03%
Highest days to cover
38.38 (28 Feb 2023)
SEC filings marked
10

Every report in 2023

OptiNose, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20233.31%21.05
31 Jan 20233.15%18.28results (8-K)
15 Feb 20233.02%20.23
28 Feb 20233.04%38.38
15 Mar 20232.21%9.2010-K filed, results (8-K)
31 Mar 20232.32%16.82
14 Apr 20232.26%17.58
28 Apr 20232.18%17.37
15 May 20232.16%13.4410-Q filed, results (8-K)
31 May 20232.14%3.17
15 Jun 20232.13%3.49
30 Jun 20233.27%2.40
14 Jul 20234.09%9.52
31 Jul 20233.41%7.53results (8-K)
15 Aug 20233.40%10.0410-Q filed, results (8-K)
31 Aug 20233.29%14.26
15 Sep 20234.05%15.27
29 Sep 20233.44%13.01
13 Oct 20233.36%12.63
31 Oct 20233.39%13.50
15 Nov 20233.33%17.7710-Q filed, results (8-K)
30 Nov 20233.26%16.40
15 Dec 20233.30%6.90
29 Dec 20233.27%10.70

See also: OptiNose, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.